LDX — Lumos Diagnostics Holdings Share News
0.000.00%
- AU$84.05m
- AU$70.34m
- $13.19m
Australia's Lumos Diagnostics soars on bagging purchase order for diagnostic test
Brief: Lumos Diagnostics Receives $767,800 Febridx Order From Phase Scientific
Brief: Lumos Diagnostics Signs Exclusive Distribution Agreement For Febridx In Romania
Brief: Lumos Diagnostics Posts FY26 Revenue Rises 6% To $13.2 Million
Brief: Lumos Diagnostics Holdings Secures Contract To Manufacture Micro-Pak Mold Analyzer System
Australia's Lumos Diagnostics rises on obtaining $1.3 million purchase order
Brief: Lumos Diagnostics Receives Largest Febridx Order To Date
Brief: Lumos Diagnostics Announces Share Purchase Plan To Raise About A$2.0 Million
Brief: Lumos Diagnostics Says US FDA Grants Clia Waiver For Febridx
Australia's Lumos Diagnostics gains as US FDA grants waiver for FebriDx
Brief: Lumos Diagnostics Seeks Trading Halt Pending Update On FDA Response
Brief: Lumos Diagnostics Loss For Half-Year Attributable $4.9 Million
Brief: Lumos Diagnostics Posts Qtrly Unaudited Revenue of $2.7 Million
Brief: Lumos Diagnostics Secures Follow On Contract With Aptatek
Brief: Lumos Diagnostics Secures Distribution For Febridx In Baltic Region
Australia's Lumos Diagnostics after securing full medicare reimbursement recognition
Australia's Lumos Diagnostics rises after collaboration with AcuityMD
Brief: Lumos Diagnostics Enters Strategic Collaboration With AcuityMD
Australia's Lumos Diagnostics hits 3-1/2-year high on sales jump